Profil
Caroline Diaz is currently Director-Regulatory Affairs at Dova Pharmaceuticals, Inc. Formerly, Ms. Diaz was Senior Vice President-Regulatory Affairs at Verona Pharma Ltd. from 2021 to 2025 and Vice President-Regulatory Affairs at ReViral Ltd. Education includes undergraduate studies at Hope College and graduate studies at the University of North Carolina at Chapel Hill.
Postes actifs de Caroline Diaz
| Sociétés | Poste | Début |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Caroline Diaz
| Sociétés | Poste | Fin |
|---|---|---|
| VERONA PHARMA PLC | Conseiller Juridique Général | 01/12/2025 |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Conseiller Juridique Général | - |
Formation de Caroline Diaz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Hope College
Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















